New FDA approval for Enzalutamide
Enzalutamide, also known under the branded name Xtandi, has recently received a new FDA approval. In 2012, Enzalutamide was approved for the treatment of Non-Metastatic
Enzalutamide, also known under the branded name Xtandi, has recently received a new FDA approval. In 2012, Enzalutamide was approved for the treatment of Non-Metastatic
The main concern of many men recently diagnosed with prostate cancer is becoming incontinent or impotent after receiving the treatment. When you are diagnosed with
Scientists presenting data at a recent symposium showcased how effective treatment with androgen deprivation therapy (ADT) and enzalutamide can be for prostate cancer. The One-Two
African American men suffer from prostate cancer more often than white men, yet new research shows that they respond as well — or even better — to advanced treatment methods.
The results of a new research study have revealed that prostate cancer is becoming less deadly, and has been in decline in both diagnoses and deaths.
New analytical research into electronic health record data classification methods may hold the key for helping model prostate cancer survival rate predictions in the future.
A new nerve grafting technique has successfully been used to combat erectile dysfunction in men who have undergone prostate removal surgery in the past, a new research paper claims.
Early results are in from a clinical trial for new prostate cancer treatment drug darolutamide, showcasing the promise of better treatment for specific types of prostate tumors.
Early results in the Phase 2 GALAHAD clinical trial for the anti-cancer drug Zejula show promise in treating patients suffering from specific types of prostate cancer.
Have you received the prostate cancer diagnosis? If yes, you may have probably been taken aback, felt distressed or even depressed. These feelings are absolutely